Clinical Trial Update: Dupilumab for Prevention of Recurrence of CRSwNP After ESS [Phase 4]

View source ↗

Summary

Phase 4 trial completion update for dupilumab aimed at preventing recurrence of chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | Status: COMPLETED